Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MandA

- PMLiVE

Allergan agrees to shareholder meeting on Valeant bid

Pershing Square Capital convinces shareholders to request consultation

- PMLiVE

Valeant extends Allergan bid deadline to end of 2014

Acquisition saga carries on beyond original August 15 deadline

Allergan logo

Allergan sues Valeant and Pershing for insider trading

Botox manufacturer alleges hedge fund fraudulently built up stake in the company

Allergan logo

Allergan wields axe to fend off Valeant

Plans to cut 1.500 jobs in sign of independence

- PMLiVE

FDA approves drug for rare swelling diseases

Salix and Pharming’s Ruconest is made from the milk of genetically-modified rabbits

Allergan logo

Pershing mounts assault on Allergan board

Proposes new directors to secure Valeant takeover

- PMLiVE

Valeant takeover bid for Allergan turns hostile

Canadian firm goes directly to shareholders with offer

- PMLiVE

Allergan rebuffs Valeant once again

Could lead to hostile takeover bid

- PMLiVE

Valeant steps up pressure on Allergan with raised bid

Ups price yet again in attempt to acquire company behind Botox

- PMLiVE

Valeant sweetens Allergan offer with help from Nestle deal

Will divest skincare treatments to sidestep product conflict issues

- PMLiVE

Battle lines drawn as Allergan rejects Valeant offer

Turns down $47bn takeover bid saying it undervalues the company

- PMLiVE

Allergan resists Valeant’s advances

Threatens to derail proposed $45bn merger

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links